cancer gene therapy (Copernicus)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namecancer gene therapy (Copernicus)
Drug Alias Namecancer gene therapy (LXR/Copernicus)
ClassificationBiologics
Mechanisms of ActionApoptosis modulators
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLxr Biotechnology Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A